WANBURY
|
The Current P/E Ratio of WANBURY is 13.60.
Share Price | ₹219.7 | Jan 28,2025 |
Market Cap | ₹720.5 Cr | |
Earnings-TTM | ₹53.0 Cr | TTM-Consolidated Results |
Price/Earnings | 13.60x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WANBURY
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹720.5 Cr] as on Jan 28,2025
(/) Earnings [ ₹53.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 13.60x ]
Thus, for WANBURY , the investors are currently willing to pay 13.60 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WANBURY !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WANBURY over the last five years.
Historical PE (Price/Earnings) ratio chart of WANBURY
PE Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.53x.
- WANBURY 's operated at median p/e ratio of 0.71x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 8.54x.
- WANBURY 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does WANBURY 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WANBURY | 52.96 | 13.60 | 720.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 36.75 | 409,303.0 |
CIPLA LTD | 5,000.43 | 22.93 | 114,645.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.14 | 98,449.5 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 21.30 | 91,587.4 |
DIVIS LABORATORIES LTD | 1,836.00 | 78.10 | 143,389.0 |
MANKIND PHARMA LTD | 2,050.73 | 49.47 | 101,440.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 60.24 | 112,169.0 |
LUPIN LTD | 2,651.94 | 34.81 | 92,321.3 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.36 | 66,080.7 |
ABBOTT INDIA LTD | 1,284.66 | 42.59 | 54,708.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WANBURY 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 13.60x |
Max industry PE | 78.10x |
Median industry PE | 34.81x |
Average industry PE | 36.03x |
You may also like the below Video Courses